Join us at BRI on Saturday, March 22 between 9 a.m. and 1 p.m. for our T1D Risk Screening Event. Offered through the TrialNet Pathway to Prevention Study, risk screening uses a simple blood test that can detect your risk of T1D years before symptoms appear.
You qualify for free risk screening if you:
- Are between the ages of 2 and 45 years and have a parent, brother/sister, or child with T1D
- Are between the ages of 2 and 20 years and have an aunt/uncle, cousin, grandparent, niece/nephew, or half-brother/sister with T1D
- Have not been diagnosed with diabetes
Free parking is available for attendees who RSVP in advance.
Where
Benaroya Research Institute
1201 9th Ave
Seattle, WA 98101
View on map
March 22, 2025
9 a.m. − 1 p.m.
Add to Google · Outlook Web · Outlook Mobile · Yahoo · iCal
Questions?
The Center for Clinical Immunology would be happy to answer any questions you might have.
January 28, 2025
Interview with Dr. Megan Smithmyer: Type 1 Diabetes Biorepository (BRIDge Study)
Dr. Smithmyer is a staff scientist at Benaroya Research Institute (BRI) in the Center for Interventional Immunology. She has kindly agreed to speak with us about what the BRIDge Biorepository is and its importance to the work that scientists like her do in the realm of type 1 diabetes.
October 23, 2024
Innovation Fund Spotlight: Lab-Grown Beta Cells Meet State-Of-The-Art Imaging To Answer New Questions About Type 1 Diabetes
BRI investigators Eddie James, PhD, and Caroline Stefani, PhD, are teaming up to take a unique approach to type 1 diabetes research.
October 4, 2024
Kurt Griffin, MD, PhD: Exploring New Ways to Prevent Type 1 Diabetes
Learn about exciting new type 1 diabetes research Dr. Griffin is taking on at BRI.
